Docusign Envelope ID: DF77BEE3-3CAF-43F7-80C6-FC99624E9E9D 

## **SYBIL EASTWOOD MEMORIAL TRUST** 

**ACCOUNTS FOR THE YEAR ENDED 5TH APRIL 2025** 

**Ashtons Legal LLP Bury St Emunds Suffolk** 

**MBN/063406-0001** 



Docusign Envelope ID: DF77BEE3-3CAF-43F7-80C6-FC99624E9E9D 

## **SYBIL EASTWOOD MEMORIAL TRUST** 

## **INDEX** 

|1.<br>2.<br>3.<br>4.<br>5.<br>6.<br>7.<br>8.|**Page**<br>Trustees' Approval<br>1<br>Trust Summary<br>2<br>Balance Sheet<br>3<br>Capital Account<br>4<br>Income Account<br>5<br>Investment Schedule<br>6  -  13<br>Appendix I<br>Schedule of Donations Made<br>14  -  15<br>Appendix II<br>16<br>Summary of Income|
|---|---|





Docusign Envelope ID: DF77BEE3-3CAF-43F7-80C6-FC99624E9E9D 

## **SYBIL EASTWOOD MEMORIAL TRUST** 

## **TRUSTEES' APPROVAL** 

We, the Trustees of the Sybil Eastwood Memorial Trust do hereby declare that we have examined and approve the accounts as set out herein; a copy of which has been supplied to us. 

05-Feb-2026 | 16:11:42 GMT **Jennifer Ann Pratt Date** 

05-Feb-2026 | 16:30:21 GMT **Michael David Frape Date** 

Page 1 



Docusign Envelope ID: DF77BEE3-3CAF-43F7-80C6-FC99624E9E9D 

## **SYBIL EASTWOOD MEMORIAL TRUST** 

## **TRUST SUMMARY** 

Sybil Eastwood died on the 26th of June 1969.  By her Will dated 21st December 1962 she appointed Walter Harry Kester of Few & Kester and Felix James Chivers of 51 Green Street, London as her Trustees. 

Mrs Eastwood left her residue for the promotion, maintenance and advancement of any branch or branches of science or scientific research, but so that no part of the Trust Fund shall be applied otherwise than for a charitable purpose. 

**Trustees:** Jennifer Ann Pratt Michael David Frape (Appointed 31st March 2016) Hywel Wyn Griffiths (Retired 31st March 2016) 

**Stockbrokers:** Rathbones (formerly Investec Wealth & Investment UK) 

**Charity Reference:** Charity Commission Number: 262273 

The above summary is intended as an aide-memoire only and reference should be made to the original Trust Deed/Documents before making any decisions. 

Page 2 



Docusign Envelope ID: DF77BEE3-3CAF-43F7-80C6-FC99624E9E9D 

## **THE SYBIL EASTWOOD MEMORIAL TRUST** 

## **BALANCE SHEET AS AT 5TH APRIL 2025** 

|Brought Forward from Capital Account (Page 4)<br>Brought Forward from Income Account (Page 5)<br>**Represented by:**<br>Rathbones Portfolio of Stocks & Shares (Pages  6 - 13)<br>(Market Value as at 5th April 2025)<br>**Current Assets**<br>Ashtons Legal - Client Account<br>Rathbones - Capital Account<br>Money transferred from Rathbones but not yet credited to Ashton's<br>Client Ledger by 5th April 2025|31,777.16<br>8,166.89<br>6,341.44|**£**<br>892,872.35<br>36,306.98|
|---|---|---|
|||£929,179.33|
|||882,516.29<br>46,285.49|
|||£928,801.78|



Page 3 



Docusign Envelope ID: DF77BEE3-3CAF-43F7-80C6-FC99624E9E9D 

## **THE SYBIL EASTWOOD MEMORIAL TRUST** 

## **CAPITAL ACCOUNT** 

## **FOR THE YEAR ENDED 5TH APRIL 2025** 

|Balance Brought Forward as at 6th April 2024<br>**Plus:**<br>Gains from Sale of Investments (Page 13)<br>Accumulated Income transferred from Income Account (Page 5)<br>Excess Reportable Income from Income Account (Page 5)<br>Cost adjustments<br>**Less:**<br>**Rathbones**<br>Management Fees for the year to 5th April 2025<br>8,578.62<br>**Carried Forward to Balance Sheet as at 5th April 2025 (Page 3)**|**£**<br>856,074.31<br>45,197.23<br>169.58<br>0.00<br>9.85|
|---|---|
||901,450.97<br>8,578.62|
||£892,872.35|



Page 4 



Docusign Envelope ID: DF77BEE3-3CAF-43F7-80C6-FC99624E9E9D 

## **THE SYBIL EASTWOOD MEMORIAL TRUST** 

## **INCOME ACCOUNT** 

## **FOR THE YEAR ENDED 5TH APRIL 2025** 

**£** 

|Balance Brought Forward as at 6th April 2024<br>**Rathbones (Appendix II, Page 16)**<br>**Interest**<br>Deposit Interest<br>215.35<br>UK Fixed Interest - Paid Gross<br>3,199.31<br>UK Unit Trusts Interest - Paid Gross<br>-147.73<br>Overseas Interest - Paid Gross<br>2,870.19<br>Excess Reportable Income<br>0.00<br>**Dividends**<br>UK Equity Dividends - Paid Gross<br>8,445.54<br>UK Unit Trusts Dividends - Paid Gross<br>1,363.91<br>Overseas Dividends - Net<br>7,580.65<br>Excess Reportable Income<br>0.00<br>Real Estate - Paid Gross<br>2,497.92<br>Ashtons Legal Client Account Interest<br>**Less:**<br>**Income transferred to Capital Account (Page 4)**<br>Excess Reportable Income<br>0.00<br>Accumulated Income<br>169.58<br>Charity Donations<br>0.00<br>**Ashtons Legal**<br>Professional fees for the year to 5th April 2025<br>4,620.00<br>**Carried Forward to Balance Sheet as at 5th April 2025 (Page 3)**|14,746.42<br>26,025.14<br>325.00|
|---|---|
||41,096.56<br>4,789.58|
||£36,306.98|



Page 5 



Docusign Envelope ID: DF77BEE3-3CAF-43F7-80C6-FC99624E9E9D 

## **THE SYBIL EASTWOOD MEMORIAL TRUST** 

## **INVESTMENT SCHEDULE** 

## **FOR THE YEAR ENDED 5TH APRIL 2025** 

|**No.**<br>**Holding**<br>**Acq. Cost**<br>**Movement During Year**<br>**Gain/(Loss)**<br>Aberforth UK Small Aberforth Cos Dis<br>29/07/24: Purchase of 43 shares for £9,890.43<br>01/01/25: Equalisation of £79.43<br>47<br>Air Pods & Chems COM USD1<br>10,313.32<br>95<br>Alphabet Inc Cap Stk USD0.001<br>9,981.68<br>Amazon Com Inc USD0.01<br>13/06/24: Purchase of 73 shares for £10,737.98<br>360<br>Anglo American<br>USD 0.54945<br>10,005.75<br>25/04/24: Purchase of 310 shares for £7,931.95<br>12/12/24: Sale of 249 shares for £6,306.74 with an acquistion cost of<br>£6,694<br>(387.26)<br>231<br>Anheuser-Busch Inb NPV<br>9,356.36<br>24/07/24: Sale of 231 shares for £10,797.13 with an acquisiton cost<br>of £9,356.36<br>1,440.77<br>19<br>ASML Holding Nv Eur0.09<br>9,969.04<br>500<br>Assa Abloy Ser 'B' NPV<br>9,516.92<br>16/12/24: Sale of 500 shares for £12,273.87 with an acquisition cost<br>of £9,516.92<br>2,756.95<br>47,200<br>Assura Plc<br>Ord GBP0.10<br>27,426.67<br>170<br>Astrazeneca<br>Ordinary US$0.25<br>7,377.88<br>12/06/24: Sale of 40 shares for £5,010.81 with an acquisition cost of<br>£1,735.97<br>3,274.84<br>17,800<br>Bbgi Gbl Infrstr S Ord Npv (Di)<br>24,629.80<br>BECTON Dickinson<br>16/01/25: Purchase of 55 shares for £10,478.39<br>8,800<br>Blackrock Frontier Inv Trust Plc<br>US$0.01 Shares<br>10,045.71<br>BNP Paribas Issuan 172.80% S&P Call<br>Spd 31<br>07/11/24: Purchase of 38,700 shares for £30,994.12<br>14,600<br>BNP Paribas Issuan 677% Topix<br>100-140 29<br>14,491.96<br>3<br>Booking Hldgs Inc<br>Com USD 0.008<br>4,662.45<br>**On hand at 6th April 2024**|**On hand at 5th April 2025**|
|---|---|
||**No.**<br>**Acq. Cost**<br>**Market**<br>**Value**<br>43<br>9,811.00<br>8,404.00<br>47<br>10,313.32<br>9,570.00<br>95<br>9,981.68<br>10,690.00<br>73.00<br>10,737.98<br>9,647.00<br>421<br>11,243.70<br>7,714.00<br>0<br>0.00<br>0.00<br>19<br>9,969.04<br>9,101.00<br>0<br>0.00<br>0.00<br>47,200<br>27,426.67<br>21,651.00<br>130<br>5,641.91<br>14,049.00<br>17,800<br>24,629.80<br>24,973.00<br>55<br>10,478.39<br>8,813.00<br>8,800<br>10,045.71<br>12,386.00<br>38,700<br>30,994.12<br>26,382.00<br>14,600<br>14,491.96<br>26,414.00<br>3<br>4,662.45<br>9,932.00|



equalisation 

Page 6 



Docusign Envelope ID: DF77BEE3-3CAF-43F7-80C6-FC99624E9E9D 

## **THE SYBIL EASTWOOD MEMORIAL TRUST** 

## **INVESTMENT SCHEDULE** 

## **FOR THE YEAR ENDED 5TH APRIL 2025** 

|**No.**<br>**Holding**<br>**Acq. Cost**<br>**Movement During Year**<br>**Gain/(Loss)**<br>**On hand at 6th April 2024**<br>2,700<br>BA Beutel Goodman Us Value C G<br>29,035.14<br>11/06/24: Sale of 700 shares for £10,059 with an acquisition cost of<br>£7,527.63<br>28/08/24: Sale of 1,994 shares for £29,251.98 with an acquisition<br>cost of £21,442.99<br>18/03/25: Sale of 6 shares for £83.76 with an acquisition cost of<br>£64.52<br>10,359.60<br>319<br>Capital Gearing Tr<br>Ord GBP 0.25<br>14,143.09<br>25/04/24: Sale of 159 shares for £7,470.93 with an acquisition cost of<br>£7,049.38<br>07/08/24: Sale of 160 shares for £7,583.98 with an acquisition cost of<br>£7,093.71<br>911.82<br>Citigroup Gbl Lux 8.95% FTSE/S&P<br>23/01/25: Purchase of 24,300 shares for £24,300<br>120<br>CG Portfolio Fund<br>Real Return A £1<br>16,258.28<br>75<br>CG Portfolio Fund<br>Capital Gearing Pft V GBP<br>(was The Capital Value V GBP)<br>7,598.75<br>Credit Agricols 267% Eurostoxx Acell<br>2031<br>22/11/24: Purchase of 21,070 shares for £21,070<br>480<br>Diageo Plc<br>Ordinary 28.935185 Shares<br>734.56<br>2,073<br>Dowlais Group Plc Ord GBP0.01<br>2,209.95<br>07/08/24: Sale of 2,073 shares for £1,277.92 with an acquisition cost<br>of £2,209.95<br>(932.03)<br>120<br>Ennismore Fund Management<br>European Smaller Companies<br>Dis £1<br>2,552.65<br>20/11/24: Sale of 60 shares for £9,415.64 with an acquisition cost of<br>£1,276.33<br>8,139.31<br>450<br>Experian Group Plc<br>New Ordinary US$ 0.10 Shares<br>2,464.06<br>11,900<br>Fedrtd Hrms Inv FH Asia Ex Jpn Eq<br>26,712.02<br>330<br>Fevertree Drinks Ord GBP 0.025<br>6,729.00<br>260.000<br>Findlay Park Fds American Sterling<br>GBP Uhdg (was American USD)<br>17,308.74<br>26/07/24: Sale of 60 shares for £10,348.80 with an acquisition cost of<br>£3,994.32<br>28/08/24: Sale of 47 shares for £8,010.21 with an acquistion cost of<br>£3,128.89<br>11,235.80<br>2,760<br>Fundsmith LLP<br>Equity I Inc Nav<br>12,269.48<br>01/07/24: Equalisation of £2.31<br>06/11/24: Sale of 2,760 shares for £17,839.81 with an acquistion cost<br>of £12,267.17<br>5,572.64|**On hand at 5th April 2025**|
|---|---|
||**No.**<br>**Acq. Cost**<br>**Market**<br>**Value**<br>0<br>0.00<br>0.00<br>0<br>0.00<br>0.00<br>24,300<br>24,300.00<br>22,113.00<br>120<br>16,258.28<br>22,425.00<br>75<br>7,598.75<br>13,530.00<br>21,070.00<br>21,070.00<br>23,634.00<br>480<br>734.56<br>9,660.00<br>0<br>0.00<br>0.00<br>60<br>1,276.32<br>9,768.00<br>450<br>2,464.06<br>14,609.00<br>11,900<br>26,712.02<br>29,895.00<br>330<br>6,729.00<br>2,473.00<br>153.000<br>10,185.53<br>24,529.00<br>0<br>0.00<br>0.00|



Page 7 



Docusign Envelope ID: DF77BEE3-3CAF-43F7-80C6-FC99624E9E9D 

## **THE SYBIL EASTWOOD MEMORIAL TRUST** 

## **INVESTMENT SCHEDULE** 

## **FOR THE YEAR ENDED 5TH APRIL 2025** 

|**No.**<br>**Holding**<br>**Acq. Cost**<br>**Movement During Year**<br>**Gain/(Loss)**<br>**On hand at 6th April 2024**<br>17,600<br>Greencoat UK Wind Ord GBP 0.01<br>23,640.94<br>28/08/24: Sale of 3,015 shares for £4,269.24 with an acquisition cost<br>of £4,049.85<br>219.39<br>750<br>Halma<br>Ordinary 10p Shares<br>7,168.84<br>02/10/24: Sale of 175 shares for £4,522.62 with an acquisition cost of<br>£1,672.73<br>2,849.89<br>570<br>Herald Inv Trust Ord GBP 0.25<br>9,349.80<br>Honeywell Intl Inc<br>19/12/24: Purchase of 59 shares for £10,739.71<br>1,630<br>HSBC Holdings Plc<br>Ord USD 0.50 (UK Reg)<br>6,823.13<br>4,850<br>Ishares Ii Plc USD Tips<br>Ucits Etf GBP Dis<br>25,500.47<br>13/11/24: Sale of 4,850 shares for £23,503.59 with an acquistion cost<br>of £25,500.47<br>(1,996.88)<br>Ishares Ii Plc USD Tips<br>0-5 Ucits GBP Dis<br>13/11/24: Purchase of 4,800 shares for £23,361.60<br>Ishares Iii Plc S&P 500 Equal Weight<br>Ucits<br>19/01/25: Purchase of 43 shares for £212.46<br>20/12/25: Purchase of 2,140 shares for £10,532.01<br>156<br>Invesco Physical Secured Gold<br>Lkd Nts USD<br>20,629.37<br>28/08/24: Sale of 41 shares for £7,479.61 with an acquisition cost of<br>£5,421.82<br>2,057.79<br>58<br>Invesco Physical Secured Gold<br>Lkd Nts 31/12/<br>8,940.85<br>19,317<br>INT Public Partner<br>Ordinary 0.0001p Shares<br>28,023.86<br>28/08/24: Sale of 4,940 shares for £6,352.84 with an acquistion cost<br>of £7,166.63<br>24/01/25: Sale of 4,802 shares for £5,385.82 with an acquistion cost<br>of £6,966.43<br>29/01/25: Sale of 9,575 shares for £10,616.41 with an acquistion cost<br>of £13,890.79<br>(5,668.78)<br>76<br>Johnson & Johnson COM USD1.00<br>10,149.38<br>06/03/25: Sale of 76 shares for £9,685.96 with an acquistion cost of<br>£10,149.38<br>(463.42)<br>77<br>JPMorgan Chase & Co<br>COM USD1.00<br>8,649.60<br>20,676<br>Lazard Invtmnt Fds Emerging Markets<br>J GBP Dis<br>19,214.42<br>13,860<br>Londonmetric Prop Ord GBP.10<br>24,467.60<br>Marcadolibre Inc COM USD0.001<br>16/05/24: Purchase of 6 shares for £8,269.30|**On hand at 5th April 2025**|
|---|---|
||**No.**<br>**Acq. Cost**<br>**Market**<br>**Value**<br>14,585<br>19,591.09<br>15,329.00<br>575<br>5,496.11<br>14,392.00<br>570<br>9,349.80<br>10,197.00<br>59<br>10,739.71<br>8,708.00<br>1,630<br>6,823.13<br>12,389.00<br>0<br>0.00<br>0.00<br>4,800<br>23,361.60<br>23,525.00<br>2,183<br>10,744.47<br>9,658.00<br>115<br>15,207.55<br>25,900.00<br>58<br>8,940.85<br>13,108.00<br>0<br>0.00<br>0.00<br>0<br>0.00<br>0.00<br>77<br>8,649.60<br>12,513.00<br>20,676.3574<br>19,214.42<br>22,558.00<br>13,860<br>24,467.60<br>24,913.00<br>6<br>8,269.30<br>8,538.00|



Page 8 



Docusign Envelope ID: DF77BEE3-3CAF-43F7-80C6-FC99624E9E9D 

## **THE SYBIL EASTWOOD MEMORIAL TRUST** 

## **INVESTMENT SCHEDULE** 

## **FOR THE YEAR ENDED 5TH APRIL 2025** 

|**No.**<br>**Holding**<br>**Acq. Cost**<br>**Movement During Year**<br>**Gain/(Loss)**<br>**On hand at 6th April 2024**<br>Marsh & McLennan COM USD1.00<br>19/02/25: Purchase of 60 shares for £11,045.60<br>86<br>Medtronic Plc<br>USD0.0001<br>7,936.07<br>16/01/25: Sale of 86 shares for £5,969.23 with an acquisition cost of<br>£7,936.07<br>(1,966.84)<br>Melrose Indust Plc<br>Ord GBP0.001<br>06/03/25: Purchase of 1,700 shares for £9,848.47<br>2,073<br>Melrose Indust Plc<br>Ord GBP0.22857142<br>7,798.00<br>10/02/25: Sale of 2,073 shares for £12,812.71 with an acquistion cost<br>of £7,798<br>5,014.71<br>Microsoft Corp COM USD0.00000625<br>07/08/24: Purchase of 30 shares for £9,657.11<br>7,200<br>M&G Investment Fd (1) Japan Sterling<br>Pp Acc<br>10,546.46<br>01/03/24: Accumulation of £71.82<br>02/09/24: Accumulation of £97.76<br>104<br>Nestle SA CHF0.10 (Regd)<br>9,877.09<br>13/11/24: Sale of 104 shares for £7,166.24 with an acquistion cost of<br>£9,877.09<br>(2,710.85)<br>160<br>Nvidia Corp COM USD0.001<br>10,057.80<br>145<br>Novartis Ag CHFO .50 (Regd)<br>9,722.25<br>134<br>Novo Nordisk A/s Ser 'B' DKK0.1<br>9,824.89<br>530<br>Pershing Sq Holdings NPV<br>14,608.80<br>Persimmon<br>Ord GBP0.10<br>17/12/24: Purchase of 870 shares for £10,824.86<br>800<br>Prudential Ordinary 5p Shares<br>9,960.29<br>206<br>Rio Tinto Plc<br>Ordinary 10p Shares<br>4,821.68<br>200<br>RIT Cap Partners<br>Ordinary £1 Shares<br>1,814.17<br>41<br>Roche Hldgs Ag<br>Genusscheine NPV<br>10,464.58<br>16/12/24: Sale of 41 shares for £9,236.92 with an acquisition cost of<br>£10,464.58<br>(1,227.66)<br>13,800<br>RYL Bk Canada (Lon) 151.40% S&P<br>Accel 28<br>14,792.71<br>2,010.00<br>Scot Mart Inv Tst Ord GBP0.05<br>15,153.59<br>13,000<br>Sequoia Economic I<br>NPV<br>14,343.49|**On hand at 5th April 2025**|
|---|---|
||**No.**<br>**Acq. Cost**<br>**Market**<br>**Value**<br>60<br>11,045.60<br>10,674.00<br>-<br>-<br>0.00<br>1,700<br>9,848.47<br>7,220.00<br>-<br>-<br>0.00<br>30<br>9,657.11<br>8,343.00<br>7,200<br>10,716.04<br>10,989.00<br>-<br>-<br>0.00<br>160<br>10,057.80<br>11,661.00<br>145<br>9,722.25<br>12,046.00<br>134<br>9,824.89<br>6,588.00<br>530<br>14,608.80<br>17,925.00<br>870<br>10,824.86<br>10,138.00<br>800<br>9,960.29<br>5,974.00<br>206<br>4,821.68<br>8,732.00<br>200<br>1,814.17<br>3,586.00<br>0<br>0.00<br>0.00<br>13,800<br>14,792.71<br>13,874.00<br>2,010<br>15,153.59<br>17,196.00<br>13,000<br>14,343.49<br>9,666.00|



accumulation 

Page 9 



Docusign Envelope ID: DF77BEE3-3CAF-43F7-80C6-FC99624E9E9D 

## **THE SYBIL EASTWOOD MEMORIAL TRUST** 

## **INVESTMENT SCHEDULE** 

## **FOR THE YEAR ENDED 5TH APRIL 2025** 

|**No.**<br>**Holding**<br>**Acq. Cost**<br>**Movement During Year**<br>**Gain/(Loss)**<br>**On hand at 6th April 2024**<br>500<br>Shell<br>Ord EURO0.07<br>7,599.17<br>Schroder Unit Trst US Smlr<br>29/07/24: Purchase of 6,180 shares for £12,211.68<br>71<br>Siemens Ag Npv (Regd)<br>9,912.28<br>SLF Realisation Frd Ord Npv B Share<br>10/10/24: Purchase of 10,398 shares for £132<br>22/10/24: Sale of 10,398 shares for £51.99 with an acquisition cost of<br>£132<br>(80.01)<br>10,398<br>SLF Realisation Fd Ord Npv<br>487.34<br>10/10/24: Return of capital £132<br>24/01/25: Sale of 10,398 shares for £93.58 with an acquisiton cost of<br>£355.34<br>(261.76)<br>510<br>SSE Plc GBP 0.50<br>6,553.33<br>23<br>Thermo Fisher Scie COM USD1<br>9,610.41<br>13,495<br>Twentyfour Income<br>Ordinary Red 1p Shares<br>14,998.98<br>240<br>Totalenergies Se EUR2.5<br>8,114.67<br>Uber Technologies COM USD0.00001<br>14/11/24: Purchase of 180 shares for £10,216.13<br>12,200<br>UK (Govt of) 0.125% Idx/Lkd Snr<br>22/03/2029 GBP<br>17,361.36<br>02/10/24: Purchase of 8,800 shares for 14,298.61<br>11/11/24: Sale of 11,000 shares for £17,724.26 with an acquistion<br>cost of £16,583.79<br>14/11/24: Sale of 10,000 shares for £16,016.07 with an acquisition<br>cost of £15,076.18<br>2,080.36<br>45,800<br>UK (Govt of) 0.625% Bds 31/07/35<br>GBP1000<br>30,542.71<br>38,700<br>UK (Govt of) 0.875% Bds 31/01/46<br>GBP1000<br>19,061.37<br>10/12/24: Sale of 38,700 shares for £18,777.24 with an acquisition<br>cost £18,961<br>(183.76)<br>20,000<br>UK (Govt of) 3.5% Bds 22/10/2025<br>GBP1000<br>19,507.85<br>08/05/24: Sale of 10,000 shares for £9,831.87 with an acquisition<br>cost of £9,644<br>15/05/24: Sale of 10,000 shares for £9,843 with an acquisiton cost of<br>£9,644<br>386.87<br>40,300<br>UK (Govt of) 3.25% Bds 31/01/33<br>GBP1000<br>37,399.64<br>02/10/24: Sale of 20,300 shares for £19,282.77 with an acquistion<br>cost of £18,594<br>688.77|**On hand at 5th April 2025**|
|---|---|
||**No.**<br>**Acq. Cost**<br>**Market**<br>**Value**<br>500<br>7,599.17<br>12,409.00<br>6,180<br>12,211.68<br>10,413.00<br>71<br>9,912.28<br>11,012.00<br>-<br>-<br>0.00<br>-<br>-<br>0.00<br>510<br>6,553.33<br>8,166.00<br>23<br>9,610.41<br>7,784.00<br>13,495<br>14,998.98<br>14,669.00<br>240<br>8,114.67<br>10,815.00<br>180<br>£10,216.13<br>8,989.00<br>0<br>£0.00<br>0.00<br>45,800<br>30,542.71<br>31,505.00<br>-<br>-<br>-<br>-<br>-<br>-<br>20,000<br>18,805.64<br>18,775.00|



Page 10 



Docusign Envelope ID: DF77BEE3-3CAF-43F7-80C6-FC99624E9E9D 

## **THE SYBIL EASTWOOD MEMORIAL TRUST** 

## **INVESTMENT SCHEDULE** 

## **FOR THE YEAR ENDED 5TH APRIL 2025** 

|**On hand at 6th April 2024**|**Acq. Cost**<br>**Movement During Year**<br>29/08/24: Purchase of 51,960 shares for £53,089.61<br>112.53<br>03/10/24: Purchase of 340 shares for £6,766.57<br>13/11/24: Purchase of 181 shares for £19,866.56<br>07/05/24: Purchase 48 shares for £10,507.01<br>7,974.37<br>10,696.92<br>5,230.95<br>11/12/24: Sale of 800 shares for £7,021.44 with an acquisition cost of<br>£5,230.95<br>17,916.81<br>01/05/24: Equalisation of £63.04<br>21/11/24: Sale of 2,100 shares for £11,015.76 with an acquisition<br>cost of £8,719.28<br>853,154.08|**Gain/(Loss)**<br>1,790.49<br>2,296.48|**On hand at 5th April 2025**|**On hand at 5th April 2025**|**On hand at 5th April 2025**|
|---|---|---|---|---|---|
|**No.**<br>**Holding**<br>UK (Govt of) 4.25% Bds 31/07/34<br>GBP1000<br>300<br>Unilever Plc<br>Ordinary 0.31111p Shares<br>Universal Music Group<br>EUR10.00<br>Vanguard Funds Plc FTSE All-World<br>Ucits Etf Us<br>Visa Inc COM Stk USD0.001<br>60<br>Walt Disney Co<br>Com Disney USD0.01<br>10,000<br>Warehouse Reit Plc<br>Ordinary 1p Shares<br>800<br>WPP Group Plc<br>Ordinary 10p Shares<br>4,300<br>WS Morant Wright Jpn B Dis|||**No.**<br>**Acq. Cost**<br>51,960<br>53,089.61<br>300<br>112.53<br>340<br>6,766.57<br>181<br>19,866.56<br>48<br>10,507.01<br>60<br>7,974.37<br>10,000<br>10,696.92<br>0<br>0.00<br>2,200<br>9,134.49<br>£882,516.29||**Market**<br>**Value**<br>51,773.00<br>14,081.00<br>6,810.00<br>17,622.00<br>11,616.00<br>3,873.00<br>10,110.00<br>0.00<br>11,376.00|
|||£45,197.23||£882,516.29|£990,500.00|



Page 11 



Docusign Envelope ID: DF77BEE3-3CAF-43F7-80C6-FC99624E9E9D 

## **SYBIL EASTWOOD MEMORIAL TRUST** 

## **APPENDIX I SCHEDULE OF DONATIONS MADE** 

|**Year to 5th April 2025**<br>None Made<br>**Year to 5th April 2024**<br>Prostate Cancer UK<br>Action Medical Research<br>RVC Student Hardship Fund<br>University of Cambridge - Annual Donation 2023<br>University of Cambridge - Annual Donation 2024<br>**Year to 5th April 2023**<br>Action Medical Research<br>University of Cambridge - Gift Registry<br>**Year to 5th April 2022**<br>Action Medical Research<br>Prostate Cancer UK<br>Addenbrookes Charitable Trust<br>University of Cambridge - Gift Registry<br>British Diabetic Association<br>**Year to 5th April 2021**<br>Diabetes UK<br>Action Medical Research<br>**Year to 5th April 2020**<br>Diabetes UK<br>Action Medical Research<br>**Year to 5th April 2019**<br>None Made<br>**Year to 5th April 2018**<br>Action Medical Research<br>**Year to 5th April 2017**<br>Action Medical Research<br>**Year to 5th April 2016**<br>Action Medical Research|**£**<br>5,000.00<br>5,000.00<br>2,000.00<br>10,000.00<br>10,000.00<br>15,000.00<br>10,000.00<br>15,000.00<br>5,000.00<br>20,000.00<br>7,500.00<br>2,000.00<br>2,000.00<br>15,000.00<br>1,000.00<br>10,000.00<br>10,000.00|**£**|
|---|---|---|
|||0.00<br>32,000.00<br>25,000.00<br>49,500.00<br>17,000.00<br>11,000.00<br>0.00<br>10,000.00<br>10,000.00|



Page 12 



Docusign Envelope ID: DF77BEE3-3CAF-43F7-80C6-FC99624E9E9D 

## **SYBIL EASTWOOD MEMORIAL TRUST** 

## **APPENDIX I** 

## **SCHEDULE OF DONATIONS MADE** 

|Kidney Research UK<br>**Year to 5th April 2014**<br>Action Medical Research<br>Addenbrookes Charitable Trust (ACT)<br>Diabetes UK<br>**Year to 5th April 2013**<br>Addenbrookes<br>Action Medical Research<br>Diabetes UK<br>**Year to 5th April 2012**<br>None Made<br>**Year to 5th April 2011**<br>Action Medical Research for Children<br>(Projects for Iron Deficiency & Pregnancy Complications)<br>Cambridge University Department of Neurology<br>(Parkinson's Disease Project)<br>**Year to 5th April 2008**<br>Cambridge Arthritis Research Endeavour (C.A.R.E.)<br>**Year to 5th April 2007**<br>Cambridge Arthritis Research Endeavour (C.A.R.E.)<br>Research Into Ageing<br>**Year to 5th April 2006**<br>Cambridge Arthritis Research Endeavour (C.A.R.E.)<br>**Year to 5th April 2005**<br>Cambridge Arthritis Research Endeavour (C.A.R.E.)<br>**Year to 5th April 2004**<br>Cambridge Arthritis Research Endeavour (C.A.R.E.)<br>**Year to 5th April 2003**<br>Cambridge Arthritis Research Endeavour (C.A.R.E.)<br>(Hip Hop Study - Muscle Density Response to Targeted<br>(Children with Sickle Cell & Seizure Detection in Newborn|**£**<br>**£**<br>25,000.00<br>35,000.00<br>26,000.00<br>14,240.00<br>10,000.00<br>50,240.00<br>14,240.00<br>26,000.00<br>10,000.00<br>50,240.00<br>0.00<br>30,000.00<br>30,000.00<br>60,000.00<br>4,500.00<br>18,000.00<br>500.00<br>18,500.00<br>18,000.00<br>18,000.00<br>18,000.00<br>18,500.00|
|---|---|



Page 13 



Docusign Envelope ID: DF77BEE3-3CAF-43F7-80C6-FC99624E9E9D 

## **SYBIL EASTWOOD MEMORIAL TRUST** 

## **APPENDIX I SCHEDULE OF DONATIONS MADE** 

||**£**|**£**|
|---|---|---|
|**Year to 5th April 2002**|||
|Cambridge Arthritis Research Endeavour (C.A.R.E.)||20,000.00|



Page 14 



Docusign Envelope ID: DF77BEE3-3CAF-43F7-80C6-FC99624E9E9D 

## **SYBIL EASTWOOD MEMORIAL TRUST** 

## **APPENDIX II** 

## **SUMMARY OF INCOME** 

Page 15 

